Regeneron Pharmaceuticals Inc REGN:NASDAQ

Last Price$608.24NASDAQ Previous Close - Last Trade as of 4:00PM ET 8/10/20

Today's Change-11.97(1.93%)
Bid (Size)$605.24 (1)
Ask (Size)$608.24 (1)
Day Low / High$596.58 - 624.36
Volume624.7 K
 

View Biotechnology IndustryPeer Comparison as of 08/10/2020

 

Regeneron Pharmaceuticals Inc ( NASDAQ )

Price: $608.24
Change: -11.97 (1.93%)
Volume: 624.7 K
4:00PM ET 8/10/2020
 
 

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A
N/A
 
 

Vertex Pharmaceuticals Inc ( NASDAQ )

Price: $268.73
Change: -4.26 (1.56%)
Volume: 1.2 M
4:00PM ET 8/10/2020
 
 

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A
N/A
 
 

Illumina Inc ( NASDAQ )

Price: $353.35
Change: -2.31 (0.65%)
Volume: 951.2 K
4:00PM ET 8/10/2020
 

Read more news Recent News

Regeneron Pharma Prices $2 Billion Notes Offering Due 2030 and 2050
4:14PM ET 8/07/2020 MT Newswires

Regeneron Pharmaceuticals (REGN) said on Friday it has priced its underwritten offering of $1.25 billion of senior unsecured notes due 2030 and $750...

Consensus Q3, 2020, 2021 Estimates for Regeneron Pharmaceuticals Raised
11:50AM ET 8/07/2020 MT Newswires

Q3, 2020, and 2021`s consensus forecasts for Regeneron Pharmaceuticals Inc (NASDAQ:REGN, Recent Price: 621.21) have been raised. The Q3 earnings estimate...

--Analyst Actions: Credit Suisse Lifts Price Target on Regeneron Pharmaceuticals to $725 From $716, Maintains Outperform
11:18AM ET 8/07/2020 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

--Analyst Actions: Oppenheimer Lifts Regeneron Pharmaceuticals PT to $725 From $675 on Q2 Results, Maintains Outperform
12:47PM ET 8/06/2020 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Company Profile

Business DescriptionRegeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. View company web site for more details
Address777 Old Saw Mill River Road
Tarrytown, New York 10591-6707
Phone+1.914.847.7000
Number of Employees7,400
Recent SEC Filing08/07/2020FWP
Co-President, Chief Executive Officer & DirectorLeonard S. Schleifer
Co-President, Director & Chief Scientific OfficerGeorge Damis Yancopoulos
Chief Financial Officer & Executive VP-FinanceRobert E. Landry
Executive VP-Research & DevelopmentNeil Stahl

Company Highlights

Price Open$623.00
Previous Close$620.21
52 Week Range$271.37 - 664.64
Market Capitalization$63.6 B
Shares Outstanding104.5 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement11/03/2020

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share$23.64
Beta vs. S&P 500N/A
Revenue$6.7 B
Net Profit Margin37.30%
Return on Equity27.89%

Analyst Ratings as of 07/24/2020

Buy
14
Overweight
1
Hold
11
Underweight
1
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset